The Use of Disease-Modifying Therapies in Multiple Sclerosis: Principles and Current Evidence (version as of April 2017)
The purpose of this paper, which was developed by the member organizations of the Multiple Sclerosis Coalition, is to summarize current evidence about disease modification in multiple sclerosis (MS) and provide support for broad access to U.S. Food and Drug Administration (FDA)-approved MS disease-modifying therapies for people with MS in the United States. Click here to download PDF
MS Coalition Brochure (version as of January 26, 2012)
The Multiple Sclerosis Coalition (MSC) was founded in 2005 by three independent multiple sclerosis (MS) organizations in an effort to work together to benefit individuals with MS. Since that time, the MSC has grown to nine member organizations, all of whom provide critical MS programs and services. Click here to download the PDF
More than half of people living with #MultipleSclerosis experience mood changes at some point in the course of their disease. Learn how cognitive behavioral therapy can help you manage your emotions, as well as pain and fatigue: https://t.co/sya3KrqXAR.
We provide a toll-free Helpline that allows members of the MS community to speak directly with one of MSAA’s experienced specialists. These trained and compassionate individuals have a social services and/or counseling background. To learn more, visit: https://t.co/QlSO1RgwZZ